SCHEMBL7182708

SCHEMBL7182708

C=CC(C)(C)c1ccc(OC)c(C=CC(=O)c2ccc(N)cc2)c1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.54
CA2 P00918 3/20 0.54
KRAS P01116 1/20 0.54
PTPN1 P18031 9/20 0.52
ABCG2 Q9UNQ0 5/20 0.51
IDH1 O75874 1/20 0.51
ABCB1 P08183 1/20 0.51
UGT1A1 P22309 1/20 0.51
DPP4 P27487 1/20 0.51
ABCC1 P33527 1/20 0.51
PRMT6 Q96LA8 1/20 0.51
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TUBB1 Q9H4B7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7182704 1.00 CA1 (0.54) CA1CA2KRASPTPN1ABCG2
SCHEMBL7184800 0.90 PTPN1 (0.64) PTPN1ABCG2IDH1ABCB1UGT1A1
SCHEMBL7184806 0.90 PTPN1 (0.64) PTPN1ABCG2IDH1ABCB1UGT1A1
SCHEMBL7191169 0.89 CA1 (0.58) CA1CA2KRASPTPN1ABCG2
SCHEMBL7191166 0.89 CA1 (0.58) CA1CA2KRASPTPN1ABCG2
SCHEMBL7190991 0.87 PTPN1 (0.50) CA1CA2KRASPTPN1ABCG2
SCHEMBL7190989 0.87 PTPN1 (0.50) CA1CA2KRASPTPN1ABCG2
SCHEMBL7191420 0.87 PTPN1 (0.44) CA1CA2KRASPTPN1ABCG2
SCHEMBL7191419 0.87 PTPN1 (0.44) CA1CA2KRASPTPN1ABCG2
SCHEMBL7189483 0.84 PTPN1 (0.53) KRASPTPN1ABCG2IDH1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed